These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 3632078

  • 21. Comparison of DDS with two combined chemotherapy regimens for multibacillary leprosy. Results after 3 years of treatment. A prospective randomized multicentre study.
    Dietrich M, Wabitsch R.
    Lepr Rev; 1986; 57 Suppl 3():60-2. PubMed ID: 3573962
    [No Abstract] [Full Text] [Related]

  • 22. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five?
    Kumarasinghe SP, Kumarasinghe MP.
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):173-4. PubMed ID: 15301583
    [No Abstract] [Full Text] [Related]

  • 23. Multi-drug therapy in leprosy: an effective method of control.
    Indian J Lepr; 1984 Jun; 56(1):102-12. PubMed ID: 6548238
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B, Shrestha K, Lewis J, Hawksworth RA, Walker SL.
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The Kellersberger memorial lecture, 1984. Chemotherapy of leprosy--a tool for leprosy control.
    Levy L.
    Ethiop Med J; 1985 Jan; 23(1):31-42. PubMed ID: 3965285
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN, Christian M, Jesudasan K, Kurian N, Rao GS.
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [Abstract] [Full Text] [Related]

  • 32. Epidemiology of leprosy and response to treatment in Hong Kong.
    Ho CK, Lo KK.
    Hong Kong Med J; 2006 Jun; 12(3):174-9. PubMed ID: 16760543
    [Abstract] [Full Text] [Related]

  • 33. Combined therapy in principle and practice for the control of dapsone resistance.
    Rees RJ.
    Lepr Rev; 1978 Jun; 49(2):97-100. PubMed ID: 661485
    [No Abstract] [Full Text] [Related]

  • 34. SIMLEP: a simulation model for leprosy transmission and control.
    Meima A, Gupte MD, van Oortmarssen GJ, Habbema JD.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):215-36. PubMed ID: 10575401
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Recent trends in chemotherapy of leprosy.
    Parikh DA, Maniar JK, Parikh AC, Ganapati R.
    J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.